IPO hype is back, but the chatter often clashes with what actually shows up after listing. Oversubscription is the default, described as oversubscribed until it isn’t [4]. That gap between listing-time buzz and long-term reality matters for everyday investors.
Allocation realities and risk — Allocation isn’t guaranteed. In the Lenskart IPO, funds and retirement money reportedly flowed in, sparking questions about fund evaluation standards and manager prudence [2]. The crowd included names like SBI Innovative Opportunities Fund, SBI Focused Fund, HDFC Mutual Fund - HDFC Innovation Fund, HDFC Mutual Fund - HDFC Non Cyclical Consumer Fund, HDFC Large and Mid Cap Fund, ICICI Prudential Bharat Consumption Fund, ICICI Prudential Equity & Debt Fund, and ICICI Prudential Multicap Fund (with participation also noted from global players such as Government of Singapore and T. Rowe Price International Discovery Fund) [2].
Valuation concerns — The Lenskart pricing looks stretched: a rumored P/E around 535x and an 8x profit jump for the founder in four months. Much of the headline profit relies on non-operating income like FVTPL gains, prompting questions about true profitability [3].
Oversubscription dynamics — The hype-y signal can mislead, as listing-day oversubscription doesn’t guarantee post-listing gains or sustainable value [4].
Regulator and fairness critiques — Critics blame SEBI for lax IPO gates and worry about public money backing IPOs, calling for tighter rules and better investor guardrails [5].
Post-listing outcomes — Urban Company’s Q2 shows a net loss of ₹593.3M on revenue ₹3.8B, with revenue up year-on-year but losses widening, fueling questions about long-term value after the IPO bloom [6].
Bottom line: hype can stoke a frenzy, but real value hinges on durable profits and disciplined allocation.
References
Congratulations, you now own Lenskart shares — whether you wanted them or not!
Discussion on Lenskart IPO allocations, fund houses investing, NPS risk, and MF behavior; opinions vary on value, ethics, and risk.
View sourceLenskart IPO: Why I'm not applying and what you should consider before applying.
Discusses Lenskart IPO valuation concerns, 8x founder gain, P/E 535, FVTPL one-time gain; warns, promotes broader IPO skepticism and caution.
View sourceIt's just the nature of the beast.
Discusses IPO oversubscription, LG India and Canara Robeco funds, and user profit sentiment on Indian IPOs recently from users online.
View sourceKedia on IPO frenzy. Merchant bankers are liars but it’s their job.
Discusses IPO frenzy, valuation concerns (Lenskart), regulator role (SEBI), and investor caution vs greed; calls for due diligence.
View sourceIPO ka moh maya
Discusses Urban Company IPO performance; notes post-IPO losses; mentions Lenskart and Groww IPO analyses; general Indian stock/IPO discussion.
View source